novo nordisk weight loss news - Search News

Novo Nordisk, Hims

Barron's on MSN · 6h

Novo Nordisk Earnings Are Soon. It’s All About Weight-Loss Drug Sales.

When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated the market for the new GLP-1 weight-loss medicines. When Novo’s competitor Eli Lilly reported its earnings last week,

Investopedia · 7h

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a generic version of a Novo Nordisk diabetes and weight-loss drug as early as next year.

Reuters on MSN · 1d

Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier for this addition and over the next few months expect to finish completing test and batch validation,

Barron's on MSN · 14h

Hims & Hers Stock Jumps. A Generic Version of Novo Nordisk Diabetes Drug Is Close.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo Nordisk’s diabetes drug as soon as 2025. It reported strong quarterly earnings.

2d

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ...

1don MSN

Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

CBS News on MSN2d

Novo Nordisk's obesity-fighting drugs are fattening Denmark's economy while shrinking other sectors

Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed ... knew Ozempic and Wegovy's success could impact the ...

14h

Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?

Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.

1don MSN

Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

2don MSN

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

1don MSN

Novo Nordisk, Ascendis partner to advance once-monthly obesity drug candidate

Novo Nordisk acquires exclusive worldwide license to Ascendis Pharma’s TransCon technology for developing metabolic and ...

Fortune on MSN1d

Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in Denmark

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

13d

Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies

Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...

9d

Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

Novo Nordisk dominates diabetes treatment and obesity care, but one clinical-stage pharma company could be the next breakout ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results